Abstract
Abstract:
Successfully managing projects in the biopharmaceutical industry demands a strategic balance of planning, regulatory insight, and operational agility.
With increasing complexities in drug development, evolving regulatory requirements, and the necessity of cross-functional collaboration, project managers must continuously adapt to overcome obstacles. From ensuring compliance and managing resource constraints to mitigating risks and streamlining data integration, every phase presents critical challenges that can impact timelines, costs, and overall project success.
This session will provide a deep dive into the most pressing challenges in biopharmaceutical project management, including regulatory uncertainty, fragmented data management, resource allocation constraints, risk mitigation, and portfolio prioritization. Drawing from over 20+ years of industry experience, Peniel will present proven, real-world strategies that leverage adaptive project management, Lean Six Sigma methodologies, digital transformation, and strategic portfolio oversight to enhance efficiency, drive informed decision-making, and improve project execution.
Learning objectives:
- Through compelling case studies and practical insights, attendees will gain immediately applicable solutions to enhance project execution, ensure compliance, strengthen cross-functional collaboration, and navigate complex biopharmaceutical environments with confidence.
- Whether leading early-stage research, clinical trials, technology transfers, or commercial manufacturing, participants will leave with practical tools and methodologies to drive success in an increasingly competitive and regulated landscape.
Registration
- $0.00 - PMINJ Chapter members
- $5.00 - Non-members (no refund)
- The link to the virtual meeting will be included in
the Registration Receipt
- Download the Zoom app at: https://zoom.us/download
Speaker
Peniel Ortega, PMP is a life sciences leader who believes project management is not about managing tasks. It is about moving people and outcomes with purpose.
With more than twenty years across pharmaceuticals, biopharma, and medical devices, he has led high-impact digital transformation, CQV, CSA, and capital project initiatives that strengthen compliance, accelerate delivery, and improve performance.
A chemical engineer with an MS in Engineering Management, Peniel previously served as Associate Director of Engineering at Merck. His background as a PMP and Six Sigma Black Belt shapes a practical, risk-based approach that simplifies complexity and helps teams deliver with clarity and integrity.
Today he serves as Managing Director of PharmAllies and speaks nationally at PDA Week, Kilmer, and BioPharmaPM. His core message is simple: you do not rise to the level of your goals. You rise to the level of your systems.
